Figure 2: Potential Choke Points in Scaling Up Vaccine Production Related to Key Manufacturing Challenges

Uploaded by U.S. Government Accountability Office
License United States Government Work
Comments 0
Favorites 0
Views 4,146
Date uploaded 2021-04-20
Tags gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao21443, covid19, acip, advisorycommitteeonimmunizationpractices, cdc, centersfordiseasecontrolandprevention, coronavirusdisease2019, dod, departmentofdefense, eua, emergencyuseauthorization, fda, foodanddrugadministration, fema, federalemergencymanagementagency, hhs, departmentofhealthandhumanservices, nationalstrategy, nationalstrategyforthecovid19responseandpandemicpreparedness
Visibility public